Mosteiro, Alejandra
Coronel-Coronel, Melissa
Pedrosa, Leire
Lambea-Gil, Álvaro
Torné, Ramón
Camps-Renom, Pol
Prats-Sanchez, Luis
Marti-Fabregas, Joan
Amaro, Sergio
Ramos-Pachón, Anna
Funding for this research was provided by:
European Regional Development Fund (PI22/0105, PI22/0105, PI22/0105, PI22/0105, PI22/0105)
Instituto de Salud Carlos III (RD24/0009/0010, RD24/0009/0010, RD24/0009/0010, RD24/0009/0010, RD24/0009/0010)
Article History
Received: 17 April 2025
Revised: 13 July 2025
Accepted: 1 September 2025
First Online: 27 September 2025
Declarations
:
: The study (ClinicalTrials.gov Identifier: NCT03956485) was approved by the ethics committee of each participating hospital. Patients or their legal representatives provided informed consent for participation. In some hospitals, ethics committees indicated that consent was only required for stroke survivors and for authorization to conduct a follow-up telephone call to assess the mRS score at 3 months.
: Patients or their legal representatives provided informed consent for participation.
: The authors declare no competing interests.